Summary

The single-use assemblies market is expected to grow to USD 4.89 billion by 2029, up from USD 2.63 billion in 2024, at a CAGR of 13.2% between 2024 and 2029. Growth in this market is mainly driven by the growing adoption among CDMOs, SMEs & startups, rapid implementation and low risk of cross-contamination, growing biologics & biosimilar markets, and cost savings with single-use assemblies. Furthermore, there is a growing focus on technological developments and outsourcing services. Furthermore, emerging countries provide significant development opportunities, and the focus on capacity expansion by biopharmaceutical companies is expected to drive the market further.
“The 2D bag assemblies segment accounted for the largest share of bag assemblies segment for the single-use assemblies market in 2023.”
The bag assemblies segment of the single-use assemblies market is further divided into 2D & 3D bag assemblies. In 2023, the 2D bag assemblies segment accounted for the largest share of the global single-use assemblies market by bag assemblies. The dominance of 2D bag assemblies over 3D assemblies can be attributed to their simpler design, ease of handling, and suitability for lower-volume operations. Additionally, their ability to integrate seamlessly into automated systems and compatibility with a range of fluids, such as buffers and reagents, makes them a preferred choice for manufacturers.
“The monoclonal antibodies segment accounted for the largest share of by modalities segment for the single-use assemblies market in 2023.”
In 2023, the monoclonal antibodies segment accounted for the largest share of the global single-use assemblies market by modality. Monoclonal antibodies (mAbs) are one of the largest segments of the biotechnology drugs market. Factors The large share of the monoclonal antibodies (mAbs) segment can be attributed to the increasing demand for single-use assemblies in the manufacturing of mAbs due to low capital investment, low workforce requirements, and reductions in time-consuming changeover procedures and validation.
“In 2023, the US remained to dominate the single-use assemblies market.”
The US dominated the North American single-use assemblies market in 2023. The US is the world's largest biopharmaceutical market and the leader in biopharmaceutical research and investment. The United States also has a strong healthcare infrastructure, which encourages research and development in the life sciences. Additionally, the significant presence of many biopharmaceutical companies and growing research activities in the biotechnology industry are propelling market growth in the US. Moreover, the growing support from government bodies in the form of funds and grants is also driving the growth of the single-use assemblies market.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other
executives from various key organizations operating in the single-use assemblies
marketplace.
• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
• By Region: North America - 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%


Thermo Fisher Scientific Inc. (US); Sartorius AG (Germany); Danaher Corporation (US); Merck KGaA (Germany); Avantor, Inc. (US); are some of the key players in the single-use assemblies market.

The study includes an in-depth competitive analysis of these key players in the single-use assemblies market, with their company profiles, recent developments, and key market strategies

Research Coverage:
This research report categorizes the single-use assemblies market by product ( bag assemblies {2D bag assemblies and 3D bag assemblies}, filtration assemblies, bottle assemblies, tubing assemblies, mixing assemblies, sampling assemblies, sensor assemblies, and other single-use assembly products), solution (standard solutions and customized solutions), modality (monoclonal antibodies, vaccines, therapeutic proteins & peptides, and cell & gene therapies), application (filtration & purification applications, aseptic transfer, storage applications, sampling applications, cell culture, formulation & fill-finish applications, and mixing), end user (pharmaceutical & biopharmaceutical companies, CROs & CMOs, and academic & research institutes), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the single-use assemblies market. A thorough analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. Also, it includes new product launches, collaborations and acquisitions, and recent developments associated with the single-use assemblies market.
Reasons to buy this report
The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall single-use assemblies market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (rising adoption of single-use assemblies in biopharmaceutical manufacturing, increasing focus on advantages of single-use solutions over traditional bioprocessing, booming biologics and biosimilars market, and growing advancements in single-use assembly technologies), restraints (issues related to leachables and extractables, complex and stringent regulatory landscape for single-use products, leakage and integrity issues), opportunities (high growth in emerging economies, rising focus on expanding bioprocessing capacities), and Challenges (standardization of single-use assemblies, waste generation and disposal issues, gap between demand and supply of single-use assemblies) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products of the single-use assemblies market
• Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the single-use assemblies market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players like Thermo Fisher Scientific Inc (US), Sartorius AG (Germany), Merck KGaA (Germany), Danaher Corporation (US), Avantor, Inc. (US), Parker Hannifin Corporation (US), Saint-Gobain (France), Repligen Corporation (US), Corning Incorporated (US), Entegris (US), among others in the market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.3 STUDY SCOPE 36
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 36
1.3.2 INCLUSIONS AND EXCLUSIONS 37
1.3.3 YEARS CONSIDERED 38
1.4 CURRENCY CONSIDERED 38
1.5 STAKEHOLDERS 38
1.6 SUMMARY OF CHANGES 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
2.1.1 SECONDARY DATA 41
2.1.2 PRIMARY DATA 41
2.2 MARKET ESTIMATION METHODOLOGY 43
2.2.1 MARKET ESTIMATION 43
2.2.2 INSIGHTS FROM PRIMARY EXPERTS 46
2.2.3 TOP-DOWN APPROACH 46
2.3 MARKET GROWTH RATE PROJECTION 47
2.4 DATA TRIANGULATION 50
2.5 RESEARCH ASSUMPTIONS 51
2.6 RESEARCH LIMITATIONS 52
2.7 RISK ANALYSIS 52
3 EXECUTIVE SUMMARY 53
4 PREMIUM INSIGHTS 58
4.1 SINGLE-USE ASSEMBLIES MARKET OVERVIEW 58
4.2 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY APPLICATION AND COUNTRY, 2023 59
4.3 SINGLE-USE ASSEMBLIES MARKET, BY END USER, 2024 VS. 2029 60
4.4 SINGLE-USE ASSEMBLIES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 61
5 MARKET OVERVIEW 62
5.1 INTRODUCTION 62
5.2 MARKET DYNAMICS 63
5.2.1 DRIVERS 64
5.2.1.1 Rising adoption of single-use systems in biopharmaceutical manufacturing 64
5.2.1.2 Increasing focus on advantages of single-use solutions over traditional bioprocessing 65
5.2.1.3 Booming biologics and biosimilars market 66
5.2.1.4 Growing advancements in single-use assembly technologies 67
5.2.2 RESTRAINTS 68
5.2.2.1 Issues related to leachables and extractables 68
5.2.2.2 Complex and stringent regulatory landscape for single-use products 69
5.2.2.3 Leakage and integrity issues 70
5.2.3 OPPORTUNITIES 70
5.2.3.1 High growth in emerging economies 70
5.2.3.2 Rising focus on expanding bioprocessing capacities 71
5.2.4 CHALLENGES 72
5.2.4.1 Standardization of single-use assemblies 72
5.2.4.2 Waste generation and disposal issues 73
5.2.4.3 Gap between demand and supply of single-use assemblies 74
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 75
5.4 PRICING ANALYSIS 76
5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 76
5.4.2 AVERAGE SELLING PRICE TREND, BY REGION 80
5.5 SUPPLY CHAIN ANALYSIS 82
5.6 VALUE CHAIN ANALYSIS 84
5.7 ECOSYSTEM ANALYSIS 86
5.7.1 RAW MATERIAL SUPPLIERS 86
5.7.2 PRODUCT MANUFACTURERS 86
5.7.3 END USERS 86
5.7.4 REGULATORY BODIES 87
5.8 INVESTMENT AND FUNDING SCENARIO 88
5.9 TECHNOLOGY ANALYSIS 90
5.9.1 KEY TECHNOLOGIES 90
5.9.1.1 Filtration 90
5.9.1.2 Cell culture 90
5.9.2 COMPLEMENTARY TECHNOLOGIES 91
5.9.3 ADJACENT TECHNOLOGIES 92
5.10 PATENT ANALYSIS 93
5.11 TRADE ANALYSIS 97
5.11.1 IMPORT DATA FOR HS CODE 392390 98
5.11.2 EXPORT DATA FOR HS CODE 392390 99
5.12 KEY CONFERENCES AND EVENTS 100
5.13 REGULATORY LANDSCAPE 101
5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
5.13.2 REGULATORY FRAMEWORK 104
5.13.2.1 North America 104
5.13.2.1.1 US 104
5.13.2.1.2 Canada 105
5.13.2.2 Europe 105
5.13.2.2.1 Germany 105
5.13.2.2.2 UK 105
5.13.2.3 Asia Pacific 105
5.13.2.3.1 Japan 105
5.13.2.3.2 China 105
5.13.2.4 Latin America 105
5.13.2.4.1 Brazil 105
5.14 PORTER’S FIVE FORCES ANALYSIS 106
5.14.1 THREAT OF NEW ENTRANTS 107
5.14.2 THREAT OF SUBSTITUTES 107
5.14.3 BARGAINING POWER OF BUYERS 107
5.14.4 BARGAINING POWER OF SUPPLIERS 107
5.14.5 INTENSITY OF COMPETITIVE RIVALRY 108
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 108
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 108
5.15.2 BUYING CRITERIA 110
5.16 IMPACT OF AI/GENERATIVE AI ON SINGLE-USE ASSEMBLIES MARKET 111
5.16.1 INTRODUCTION 111
5.16.2 MARKET POTENTIAL FOR SINGLE-USE ASSEMBLIES 111
5.16.3 AI USE CASES 112
5.16.4 KEY COMPANIES IMPLEMENTING AI 113
5.16.5 FUTURE OF GENERATIVE AI ON SINGLE-USE ASSEMBLIES ECOSYSTEM 114
6 SINGLE-USE ASSEMBLIES MARKET, BY PRODUCT 115
6.1 INTRODUCTION 116
6.2 BAG ASSEMBLIES 116
6.2.1 2D BAG ASSEMBLIES 120
6.2.1.1 Growing use in buffer preparation, media storage, and harvest collection to fuel market 120
6.2.2 3D BAG ASSEMBLIES 124
6.2.2.1 Larger volume storage and transport capabilities to speed up growth 124
6.2.3 BAG ASSEMBLIES, BY APPLICATION 127
6.3 FILTRATION ASSEMBLIES 128
6.3.1 RISING FOCUS ON PREVENTING LOSSES AND MAINTAINING PRODUCT QUALITY TO BOOST MARKET 128
6.4 BOTTLE ASSEMBLIES 132
6.4.1 REDUCED DOWNTIME AND TURNAROUND TIME TO BOOST MARKET 132
6.4.2 BOTTLE ASSEMBLIES, BY APPLICATION 135
6.5 TUBING ASSEMBLIES 136
6.5.1 ENHANCED RISK MANAGEMENT AND PRODUCTION TO ENCOURAGE GROWTH 136
6.6 MIXING ASSEMBLIES 140
6.6.1 MINIMIZED OPERATOR EXPOSURE AND REDUCED DOWNTIME FOR CLEANING TO AID GROWTH 140
6.7 SAMPLING ASSEMBLIES 143
6.7.1 NEED FOR QUALITY CONTROL AND PROCESS MONITORING IN BIOPROCESSING TO AUGMENT GROWTH 143
6.8 SENSOR ASSEMBLIES 147
6.8.1 GROWING ADOPTION OF BIOPROCESSING AUTOMATION TO DRIVE MARKET 147
6.9 OTHER SINGLE-USE ASSEMBLY PRODUCTS 150
7 SINGLE-USE ASSEMBLIES MARKET, BY SOLUTION 155
7.1 INTRODUCTION 156
7.2 STANDARD SOLUTIONS 156
7.2.1 GROWING FOCUS ON CAPITAL COST AND OPERATIONAL FLEXIBILITY TO DRIVE MARKET 156
7.3 CUSTOMIZED SOLUTIONS 160
7.3.1 NEED FOR ENHANCED PROCESS EFFICIENCY IN BIOPHARMACEUTICAL MANUFACTURING TO PROMOTE GROWTH 160
8 SINGLE-USE ASSEMBLIES MARKET, BY MODALITY 164
8.1 INTRODUCTION 165
8.2 MONOCLONAL ANTIBODIES 165
8.2.1 INCREASING POPULARITY OF TARGETED THERAPY TO PROMOTE GROWTH 165
8.3 VACCINES 169
8.3.1 ONGOING NEED TO ADDRESS GLOBAL HEALTH CHALLENGES TO AUGMENT GROWTH 169
8.4 THERAPEUTIC PROTEINS & PEPTIDES 173
8.4.1 GROWING SHIFT TOWARD BIOLOGIC TREATMENTS AND PERSONALIZED MEDICINES TO BOOST MARKET 173
8.5 CELL & GENE THERAPIES 176
8.5.1 RISING R&D INITIATIVES AND COLLABORATIONS AMONG KEY PLAYERS TO FACILITATE GROWTH 176
9 SINGLE-USE ASSEMBLIES MARKET, BY APPLICATION 181
9.1 INTRODUCTION 182
9.2 FILTRATION & PURIFICATION APPLICATIONS 182
9.2.1 INCREASING FOCUS ON MANUFACTURING AFFORDABLE BIOPHARMACEUTICALS TO SPUR GROWTH 182
9.3 ASEPTIC TRANSFER 186
9.3.1 GROWING DEMAND FOR BIOLOGICS AND CELL & GENE THERAPIES TO FUEL MARKET 186

9.4 STORAGE APPLICATIONS 190
9.4.1 NEED FOR FLEXIBLE AND SCALABLE STORAGE OPTIONS TO CONTRIBUTE TO GROWTH 190
9.5 SAMPLING APPLICATIONS 193
9.5.1 INCREASING COMPLEXITY IN BIOLOGICS MANUFACTURING TO ENCOURAGE GROWTH 193
9.6 CELL CULTURE 197
9.6.1 GROWING INVESTMENTS IN SINGLE-USE BIOPROCESSING INFRASTRUCTURE TO BOOST MARKET 197
9.7 FORMULATION & FILL-FINISH APPLICATIONS 200
9.7.1 GROWING TREND OF OUTSOURCING TO PROPEL MARKET 200
9.8 MIXING APPLICATIONS 204
9.8.1 PRE-STERILIZED DESIGN AND AUTOMATED DESIGNS TO ACCELERATE GROWTH 204
10 SINGLE-USE ASSEMBLIES MARKET, BY END USER 208
10.1 INTRODUCTION 209
10.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 209
10.2.1 RISING PRODUCTION OF BIOLOGICS AND BIOSIMILARS TO SUSTAIN GROWTH 209
10.3 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS 213
10.3.1 GROWING PREFERENCE FOR OUTSOURCING RESEARCH AND MANUFACTURING ACTIVITIES TO STIMULATE GROWTH 213
10.4 ACADEMIC & RESEARCH INSTITUTES 217
10.4.1 INCREASING COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES TO FUEL MARKET 217
11 SINGLE-USE ASSEMBLIES MARKET, BY REGION 221
11.1 INTRODUCTION 222
11.2 NORTH AMERICA 222
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 227
11.2.2 US 227
11.2.2.1 Highly advanced infrastructure and private funding to facilitate growth 227
11.2.3 CANADA 231
11.2.3.1 Increasing government support for biologics manufacturing to expedite growth 231
11.3 EUROPE 234
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 238
11.3.2 GERMANY 239
11.3.2.1 High government R&D investment and facility expansions by key players to aid growth 239

11.3.3 UK 243
11.3.3.1 Increased production of novel therapies, devices, and diagnostics to stimulate growth 243
11.3.4 FRANCE 246
11.3.4.1 Rising number of research collaborations and healthcare investments to sustain growth 246
11.3.5 ITALY 249
11.3.5.1 Increasing investment in advanced biomanufacturing facilities to spur growth 249
11.3.6 SPAIN 253
11.3.6.1 Increasing development of targeted therapies to contribute to growth 253
11.3.7 REST OF EUROPE 256
11.4 ASIA PACIFIC 260
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 265
11.4.2 CHINA 265
11.4.2.1 Low manufacturing costs and high investments in biotechnology sector to encourage growth 265
11.4.3 SOUTH KOREA 269
11.4.3.1 Evolving pharmaceutical manufacturing market to accelerate growth 269
11.4.4 JAPAN 272
11.4.4.1 Robust regulatory framework and technological expertise to favor growth 272
11.4.5 INDIA 275
11.4.5.1 Low labor cost and availability of skilled professionals to propel market 275
11.4.6 AUSTRALIA 278
11.4.6.1 Increased investments in clinical trials to augment growth 278
11.4.7 REST OF ASIA PACIFIC 282
11.5 LATIN AMERICA 285
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 289
11.5.2 BRAZIL 289
11.5.2.1 Increasing adoption of cell & gene therapies to promote growth 289
11.5.3 MEXICO 293
11.5.3.1 Growing foreign direct investments to boost market 293
11.5.4 REST OF LATIN AMERICA 296
11.6 MIDDLE EAST 299
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST 302
11.6.2 GCC COUNTRIES 302
11.6.2.1 Saudi Arabia 306
11.6.2.1.1 Growing investments in healthcare infrastructure and research to fuel market 306
11.6.2.2 UAE 309
11.6.2.2.1 Rising focus on developing life science products to support growth 309
11.6.2.3 Rest of GCC countries 312
11.6.3 REST OF MIDDLE EAST 316
11.7 AFRICA 320
11.7.1 GROWING DEMAND FOR CRITICAL DRUGS TO DRIVE MARKET 320
11.7.2 MACROECONOMIC OUTLOOK FOR AFRICA 323
12 COMPETITIVE LANDSCAPE 324
12.1 OVERVIEW 324
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 324
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SINGLE-USE ASSEMBLIES MARKET 325
12.3 REVENUE ANALYSIS, 2019–2023 327
12.4 MARKET SHARE ANALYSIS, 2023 328
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 330
12.5.1 STARS 330
12.5.2 EMERGING LEADERS 331
12.5.3 PERVASIVE PLAYERS 331
12.5.4 PARTICIPANTS 331
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 333
12.5.5.1 Company footprint 333
12.5.5.2 Region footprint 334
12.5.5.3 Product footprint 335
12.5.5.4 Solution footprint 337
12.5.5.5 Application footprint 338
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 339
12.6.1 PROGRESSIVE COMPANIES 339
12.6.2 RESPONSIVE COMPANIES 339
12.6.3 DYNAMIC COMPANIES 339
12.6.4 STARTING BLOCKS 339
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 341
12.7 COMPANY VALUATION AND FINANCIAL METRICS 343
12.7.1 FINANCIAL METRICS 343
12.7.2 COMPANY VALUATION 343
12.8 BRAND/PRODUCT COMPARISON 344
12.9 COMPETITIVE SCENARIO 345
12.9.1 PRODUCT LAUNCHES 345
12.9.2 DEALS 346
12.9.3 EXPANSIONS 347

13 COMPANY PROFILES 348
13.1 KEY PLAYERS 348
13.1.1 THERMO FISHER SCIENTIFIC INC. 348
13.1.1.1 Business overview 348
13.1.1.2 Products offered 349
13.1.1.3 Recent developments 352
13.1.1.3.1 Product launches 352
13.1.1.3.2 Deals 352
13.1.1.3.3 Expansions 353
13.1.1.4 MnM view 354
13.1.1.4.1 Key strengths 354
13.1.1.4.2 Strategic choices 354
13.1.1.4.3 Weaknesses and competitive threats 354
13.1.2 SARTORIUS AG 355
13.1.2.1 Business overview 355
13.1.2.2 Products offered 356
13.1.2.3 Recent developments 358
13.1.2.3.1 Deals 358
13.1.2.3.2 Expansions 359
13.1.2.4 MnM view 360
13.1.2.4.1 Key strengths 360
13.1.2.4.2 Strategic choices 360
13.1.2.4.3 Weaknesses and competitive threats 360
13.1.3 MERCK KGAA 361
13.1.3.1 Business overview 361
13.1.3.2 Products offered 362
13.1.3.3 Recent developments 364
13.1.3.3.1 Product launches 364
13.1.3.3.2 Deals 364
13.1.3.3.3 Expansions 365
13.1.3.4 MnM view 367
13.1.3.4.1 Key strengths 367
13.1.3.4.2 Strategic choices 367
13.1.3.4.3 Weaknesses and competitive threats 367
13.1.4 DANAHER CORPORATION 368
13.1.4.1 Business overview 368
13.1.4.2 Products offered 369
13.1.4.3 Recent developments 372
13.1.4.3.1 Product launches 372
13.1.4.3.2 Deals 372
13.1.4.3.3 Expansions 372

13.1.4.4 MnM view 374
13.1.4.4.1 Key strengths 374
13.1.4.4.2 Strategic choices 374
13.1.4.4.3 Weaknesses and competitive threats 374
13.1.5 AVANTOR, INC. 375
13.1.5.1 Business overview 375
13.1.5.2 Products offered 376
13.1.5.3 Recent developments 378
13.1.5.3.1 Deals 378
13.1.5.3.2 Expansions 378
13.1.6 PARKER HANNIFIN CORPORATION 380
13.1.6.1 Business overview 380
13.1.6.2 Products offered 381
13.1.6.3 Recent developments 383
13.1.6.3.1 Expansions 383
13.1.7 SAINT-GOBAIN 384
13.1.7.1 Business overview 384
13.1.7.2 Products offered 385
13.1.7.3 Recent developments 386
13.1.7.3.1 Product launches 386
13.1.7.3.2 Deals 387
13.1.7.3.3 Expansions 387
13.1.8 REPLIGEN CORPORATION 388
13.1.8.1 Business overview 388
13.1.8.2 Products offered 389
13.1.8.3 Recent developments 391
13.1.8.3.1 Deals 391
13.1.8.3.2 Expansions 391
13.1.9 CORNING INCORPORATED 392
13.1.9.1 Business overview 392
13.1.9.2 Products offered 393
13.1.10 ENTEGRIS 395
13.1.10.1 Business overview 395
13.1.10.2 Products offered 396
13.1.10.3 Recent developments 397
13.1.10.3.1 Expansions 397
13.1.11 LONZA 398
13.1.11.1 Business overview 398
13.1.11.2 Products offered 399
13.1.12 ZACROS CORPORATION 400
13.1.12.1 Business overview 400
13.1.12.2 Products offered 401
13.1.12.3 Recent developments 402
13.1.12.3.1 Expansions 402
13.1.13 W. L. GORE & ASSOCIATES, INC. 403
13.1.13.1 Business overview 403
13.1.13.2 Products offered 403
13.2 OTHER PLAYERS 404
13.2.1 NEWAGE INDUSTRIES 404
13.2.2 WATSON-MARLOW FLUID TECHNOLOGY SOLUTIONS 405
13.2.3 COBETTER 406
13.2.4 ANTYLIA SCIENTIFIC 407
13.2.5 NUPORE FILTRATION SYSTEMS 408
13.2.6 INTELLITECH, INC. 409
13.2.7 MEISSNER FILTRATION PRODUCTS, INC. 410
13.2.8 SANISURE 411
13.2.9 SENTINEL PROCESS SYSTEMS INC. 412
13.2.10 FLUID FLOW PRODUCTS, INC. 413
13.2.11 DOVER CORPORATION 414
13.2.12 KEOFITT A/S 415
13.2.13 CELLEXUS 416
13.2.14 FOXX LIFE SCIENCES 417
13.2.15 TSE INDUSTRIES, INC. 418
14 APPENDIX 419
14.1 DISCUSSION GUIDE 419
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 423
14.3 CUSTOMIZATION OPTIONS 425
14.4 RELATED REPORTS 426
14.5 AUTHOR DETAILS 427